Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $589.66 | 29 | 97.2% |
| Education | $17.19 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $134.96 | 7 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $100.87 | 5 | $0 (2021) |
| Genentech USA, Inc. | $84.74 | 4 | $0 (2024) |
| ABBVIE INC. | $41.55 | 2 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $34.40 | 2 | $0 (2017) |
| Apellis Pharmaceuticals, Inc. | $32.27 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $29.77 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $27.08 | 1 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $25.35 | 1 | $0 (2017) |
| Alcon Vision LLC | $24.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.98 | 7 | SUN PHARMACEUTICAL INDUSTRIES INC. ($41.27) |
| 2023 | $160.69 | 8 | Genentech USA, Inc. ($59.04) |
| 2022 | $59.65 | 3 | Alcon Vision LLC ($24.05) |
| 2021 | $67.79 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($44.43) |
| 2020 | $11.99 | 1 | Allergan, Inc. ($11.99) |
| 2019 | $39.56 | 2 | Sun Pharmaceutical Industries Inc. ($39.56) |
| 2018 | $56.44 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($56.44) |
| 2017 | $59.75 | 3 | Valeant Pharmaceuticals North America LLC ($34.40) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/01/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: EYE CARE | ||||||
| 06/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Ophthalmology | ||||||
| 02/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/01/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $19.96 | General |
| 01/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | In-kind items and services | $17.19 | General |
| Category: Ophthalmology | ||||||
| 12/19/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Ophthalmology | ||||||
| 11/28/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/19/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $29.77 | General |
| 07/20/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/20/2023 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Ophthalmology | ||||||
| 06/08/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/23/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: Ophthalmology | ||||||
| 03/02/2023 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 12/08/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Ophthalmology | ||||||
| 09/23/2022 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Ophthalmology | ||||||
| 04/21/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/27/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | enVista MX60 IOL (Device), TORIC | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Ophthalmology | ||||||
| 12/20/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Ophthalmology | ||||||
| 05/27/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Ophthalmology | ||||||
| 06/29/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: GLAUCOMA | ||||||
| 04/01/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), XELPROS | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Ophthalmology | ||||||
| 02/21/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: Ophthalmology | ||||||
| 11/06/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,386 | 4,087 | $1.3M | $500,769 |
| 2022 | 17 | 2,568 | 4,456 | $1.4M | $545,831 |
| 2021 | 18 | 2,429 | 3,950 | $1.3M | $489,890 |
| 2020 | 17 | 2,726 | 3,709 | $1.1M | $405,841 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 34 | 326 | $407,500 | $225,597 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 824 | 1,114 | $194,950 | $97,634 | 50.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 62 | 103 | $216,300 | $43,800 | 20.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 92 | 418 | $108,000 | $36,195 | 33.5% |
| 92134 | Imaging of retina | Office | 2023 | 181 | 558 | $83,700 | $17,049 | 20.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 59 | 259 | $65,500 | $13,915 | 21.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 34 | 40 | $35,000 | $10,041 | 28.7% |
| 92250 | Photography of the retina | Office | 2023 | 401 | 418 | $50,160 | $9,914 | 19.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 212 | 220 | $21,960 | $9,070 | 41.3% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 13 | 15 | $33,000 | $8,851 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $19,500 | $8,357 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 105 | $12,075 | $6,650 | 55.1% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 16 | 27 | $25,650 | $5,119 | 20.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 204 | 215 | $28,250 | $4,852 | 17.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 102 | 191 | $16,550 | $3,726 | 22.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 34 | 360 | $450,000 | $256,788 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 916 | 1,207 | $211,225 | $99,264 | 47.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 72 | 466 | $116,500 | $41,089 | 35.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 57 | 89 | $186,900 | $37,934 | 20.3% |
| 92134 | Imaging of retina | Office | 2022 | 157 | 564 | $84,300 | $17,690 | 21.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 48 | 282 | $70,500 | $14,445 | 20.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 49 | 56 | $49,000 | $13,869 | 28.3% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 14 | 20 | $44,000 | $11,929 | 27.1% |
| 92250 | Photography of the retina | Office | 2022 | 467 | 486 | $58,050 | $11,839 | 20.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 228 | 237 | $23,110 | $10,559 | 45.7% |
About Dr. Douglas Scott, MD
Dr. Douglas Scott, MD is a Ophthalmology healthcare provider based in Gilford, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629064639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Scott, MD has received a total of $606.85 in payments from pharmaceutical and medical device companies, with $150.98 received in 2024. These payments were reported across 30 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($589.66).
As a Medicare-enrolled provider, Scott has provided services to 10,109 Medicare beneficiaries, totaling 16,202 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Glaucoma Specialist
- Location Gilford, NH
- Active Since 09/26/2005
- Last Updated 05/01/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1629064639
Products in Payments
- Cequa (Drug) $95.40
- Vabysmo (Drug) $84.74
- VYZULTA (Drug) $78.84
- enVista MX60 IOL (Device) $40.32
- BROMSITE (Drug) $39.56
- BESIVANCE (Drug) $34.40
- Syfovre (Drug) $32.27
- DURYSTA (Drug) $31.77
- EYLEA HD (Biological) $27.08
- Tecnis 1-piece IOL (Device) $25.35
- Clareon (Device) $24.05
- VUITY (Drug) $21.77
- DEXTENZA (Drug) $21.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.